How should a pediatric nasal spray be applied to both nostrils of an infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Apply Nasal Spray in Both Nostrils in an Infant

For infants requiring nasal spray administration, position the child upright, hold the spray bottle upright, gently insert the nozzle tip into one nostril without forcing it deep, administer the prescribed number of sprays (typically 1 spray per nostril for most medications approved for ages 2-5 years), and repeat in the other nostril. 1

Age-Specific Dosing Considerations

The term "infant" typically refers to children under 1 year of age, but most nasal sprays have limited FDA approval for this age group:

  • Intranasal steroids: The youngest FDA-approved age is ≥2 years for medications like triamcinolone acetonide (Nasacort), mometasone furoate (Nasonex), and fluticasone furoate (Veramyst) 1
  • For children ages 2-5 years, the typical dose is 1 spray per nostril once daily 1
  • For children ages 6-11 years, dosing increases to 2 sprays per nostril daily 1

Proper Administration Technique

Positioning

  • Keep both the child and the spray bottle upright during administration 2
  • This upright positioning is critical to avoid excessive medication delivery and potential systemic absorption 2

Step-by-Step Application

  1. Clear the nasal passages first if needed (using saline irrigation or gentle aspiration) 3, 4
  2. Gently insert the spray tip into the nostril—the tip should be adapted to fit infant nostrils comfortably 3
  3. Administer the prescribed number of sprays per nostril
  4. Avoid inserting the nozzle too deeply into the nasal cavity
  5. Repeat in the opposite nostril

Communication and Monitoring

  • In any medical setting, carefully monitor the quantity of medication used 2
  • The spray bottle design provides optimal lavage when used correctly in the upright position 3

Critical Safety Considerations

Decongestant Warnings

Oral and topical decongestants should be used with extreme caution or avoided entirely in infants and young children, as use in this population has been associated with serious adverse events including agitated psychosis, ataxia, hallucinations, and even death 5.

For topical nasal decongestants like oxymetazoline:

  • FDA approval is only for children ≥6 years of age 2
  • Off-label use in younger children may be considered only in specific urgent clinical scenarios where benefit clearly outweighs risk (active bleeding, acute respiratory distress) 2
  • Exercise extreme caution with both dosing quantity and administration technique due to lack of adequate pediatric pharmacokinetic studies 2

Antihistamine Nasal Sprays

Intranasal antihistamines like azelastine are approved only for children ≥12 years of age at a dose of 2 sprays per nostril twice daily 5

Practical Considerations

Ease of Administration

Studies in children ages 2-5 years found that 67-91% of parents reported nasal spray administration as either "extremely easy" or "very easy" 6, suggesting that with proper technique and age-appropriate products, nasal spray delivery is feasible in young children.

Adjunctive Measures

Before applying medicated nasal sprays, consider:

  • Saline irrigation to clear mucus and allow better medication contact with nasal mucosa 3, 4
  • This improves medication effectiveness and accelerates recovery 3
  • Isotonic saline solutions are safe and well-tolerated in infants 4

Common Pitfalls to Avoid

  1. Using the spray bottle at an angle or with the child lying down—this can lead to excessive medication delivery 2
  2. Administering medications not FDA-approved for the child's age—most nasal sprays are not approved for infants under 2 years
  3. Inserting the nozzle too deeply—this can cause discomfort and improper medication delivery
  4. Failing to clear nasal secretions first—medication is less effective when applied over thick mucus 3
  5. Using decongestants in young children—associated with serious adverse events 5

References

Guideline

clinical practice guideline: allergic rhinitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015

Research

[Treatment of acute rhinitis in neonates and infants].

Vestnik otorinolaringologii, 2004

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.